000 01175 a2200325 4500
005 20250511143902.0
264 0 _c19780814
008 197808s 0 0 eng d
022 _a0009-8981
024 7 _a10.1016/0009-8981(78)90302-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBirkett, D J
245 0 0 _aThe fatty acid content and drug binding characteristics of commercial albumin preparations.
_h[electronic resource]
260 _bClinica chimica acta; international journal of clinical chemistry
_cMay 1978
300 _a253-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aFatty Acids
_xanalysis
650 0 4 _aFluorescent Dyes
650 0 4 _aHumans
650 0 4 _aIbuprofen
650 0 4 _aPhenylbutazone
650 0 4 _aProtein Binding
650 0 4 _aSarcosine
650 0 4 _aSerum Albumin
_xanalysis
650 0 4 _aSpectrometry, Fluorescence
700 1 _aMyers, S P
700 1 _aSudlow, G
773 0 _tClinica chimica acta; international journal of clinical chemistry
_gvol. 85
_gno. 3
_gp. 253-8
856 4 0 _uhttps://doi.org/10.1016/0009-8981(78)90302-9
_zAvailable from publisher's website
999 _c677884
_d677884